Report Details:
15 Companies Covered
200 Pages
Rising Interest in Finding Treatment for Genetic Diseases to Drive Next Generation Sequencing Market Growth
Growing Demand for Personalized Medicine will Positively Impact the Global Next Generation Sequencing Market at a CAGR of 11.54% During the Forecast Period 2025 to 2035
Market Research Future (MRFR) has published a cooked research report on the “Global Next Generation Sequencing Market” that contains information from 2019 to 2035. The Next Generation Sequencing Market is projected to grow from USD 16.37 billion in 2025 to USD 48.81 billion by 2035, registering a CAGR of 11.54% during the forecast period. The market was valued at USD 14.68 billion in 2024.
MRFR recognizes the following companies as the key players in the Global Next Generation Sequencing Market — Illumina (US), Thermo Fisher Scientific (US), Pacific Biosciences (US), Oxford Nanopore Technologies (GB), BGI Genomics (CN), Qiagen (DE), Roche (CH), Agilent Technologies (US), and Genomatix (DE).
Market Highlights
The Global Next Generation Sequencing (NGS) Market is witnessing transformative growth driven by technological advancements, declining sequencing costs, and the expanding application of genomics across healthcare, agriculture, and research. The integration of artificial intelligence (AI) and machine learning (ML) for genomic data interpretation is further enhancing sequencing accuracy, efficiency, and clinical relevance.
The growing adoption of personalized medicine, increasing prevalence of genetic disorders, and rising government funding for genomic research are key factors driving market growth. In oncology, NGS is increasingly being utilized for tumor profiling, companion diagnostics, and targeted therapy development. Moreover, the expansion of sequencing applications into infectious diseases, rare disorders, and agricultural biotechnology is broadening the market’s scope.
Technological innovations such as single-molecule real-time sequencing and nanopore sequencing are revolutionizing data generation, enabling faster, more cost-effective, and portable sequencing solutions. This trend, coupled with cloud-based data analysis and collaborations between academia and industry, is expected to sustain strong market momentum through 2035.
Segment Analysis
The Global Next Generation Sequencing Market has been segmented based on Technology, Product Type, Application, End Use, and Region.
By Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Other Technologies. Among these, Sequencing by Synthesis dominates the market due to its accuracy and scalability, making it the preferred method in both research and clinical diagnostics. Meanwhile, Ion Semiconductor Sequencing is emerging as the fastest-growing technology due to its rapid processing and affordability.
Based on Product Type, the segment includes Reagents, Instruments, Software, and Services. Reagents hold the largest market share, driven by recurring demand in sequencing workflows, while Instruments are the fastest-growing category owing to innovations that improve throughput and sequencing efficiency.
By Application, the market is divided into Diagnostics, Research, Personalized Medicine, and Agrigenomics. Diagnostics remains the leading application segment due to the increasing use of NGS in genetic testing, oncology, and infectious disease diagnostics. Personalized Medicine is expected to exhibit rapid growth as genomic profiling becomes integral to treatment planning and precision healthcare.
Based on End Use, the segment includes Academic Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals and Clinics. Academic Institutes dominate the market as they lead in genomic research and large-scale sequencing projects, while Pharmaceutical Companies are the fastest-growing end-user segment due to the increasing adoption of NGS in drug discovery and companion diagnostics.
Region Analysis
By region, the Next Generation Sequencing Market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America holds the largest market share, accounting for around 45% of global revenue, driven by robust R&D funding, advanced healthcare infrastructure, and the strong presence of key industry players such as Illumina, Thermo Fisher Scientific, and Pacific Biosciences. The U.S. leads the market owing to its high adoption rate of genomics in clinical and research applications.
Europe is the second-largest market, accounting for approximately 30% of the global share. The region’s growth is supported by favorable regulatory frameworks, government initiatives in personalized medicine, and collaborations among academic and industrial stakeholders. Countries such as Germany, the UK, and France lead the regional market.
Asia-Pacific is expected to record the fastest growth during the forecast period, holding about 20% of the global market share. Rising investments in healthcare infrastructure, increasing genomics awareness, and government support for biotech innovation in China, India, and Japan are fueling growth.
The Middle East & Africa and South America collectively account for the remaining market share. Both regions are emerging markets, showing promising potential due to rising investments in genomic research and healthcare modernization initiatives, especially in countries like the UAE, South Africa, and Brazil.
Key Findings of the Study
- The Global Next Generation Sequencing Market is projected to reach USD 48.81 billion by 2035, growing at a CAGR of 11.54% from 2025 to 2035.
- Sequencing by Synthesis remains the dominant technology segment, while Ion Semiconductor Sequencing is emerging as the fastest growing.
- Reagents accounted for the largest share in 2024, driven by consistent consumption in sequencing workflows.
- Diagnostics leads the application segment, while Personalized Medicine is anticipated to grow significantly due to its clinical adoption.
- Academic Institutes dominate the end-use segment, while Pharmaceutical Companies are rapidly expanding their presence.
- North America is the largest regional market, whereas Asia-Pacific is projected to register the highest CAGR during the forecast period.
- Key players include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, BGI Genomics, Qiagen, Roche, Agilent Technologies, and Genomatix.
- Continuous advancements in sequencing speed, accuracy, and affordability, coupled with expanding applications in clinical and agricultural genomics, are driving market growth globally.
